Infectious Diseases (except HIV/AIDS)
-
Combined Impact of Prior SARS-CoV-2 Infection and Vaccination on Antibody Presence
This article has 7 authors:Reviewed by ScreenIT
-
QuaID: Enabling Earlier Detection of Recently Emerged SARS-CoV-2 Variants of Concern in Wastewater
This article has 8 authors:Reviewed by ScreenIT
-
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron
This article has 12 authors:Reviewed by ScreenIT
-
Induction of trained immunity by influenza vaccination - impact on COVID-19
This article has 24 authors:Reviewed by ScreenIT
-
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
This article has 48 authors:Reviewed by ScreenIT
-
High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination
This article has 16 authors:Reviewed by ScreenIT
-
Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment
This article has 10 authors:Reviewed by ScreenIT
-
Previous COVID-19 Infection and Antibody Levels After Vaccination
This article has 21 authors:Reviewed by ScreenIT
-
Epidemiological, clinical Characteristics and mortality of patients Infected with SARS-CoV-2 Admitted to Kinshasa University Hospital (KUH), the Democratic Republic of the Congo from March 24th, 2020, to January 30th, 2021: Two waves, two faces?
This article has 18 authors:Reviewed by ScreenIT
-
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection
This article has 8 authors:Reviewed by ScreenIT